Colorado Capitol Watch


Welcome Visitor

Forgot password?
Subscribe for Current Session

My CCW Tools

Look Up Bills

Look Up Legislators

Legislative Year: 2024 Change

Bill Detail: SB24-203

Return to list of bills

emailSend an email to your legislator

Title Prescription Drug Board Consider Rare Disease Advisory Council
Status Signed by the Speaker of the House (05/16/2024)
Bill Subjects
  • Health Care & Health Insurance
  • Insurance
House Sponsors D. Ortiz (D)
A. Hartsook (R)
Senate Sponsors J. Ginal (D)
B. Kirkmeyer (R)
House Committee Health and Human Services
Senate Committee State, Veterans and Military Affairs
Date Introduced 04/08/2024

Current law requires the Colorado prescription drug affordability
review board (board) to take certain measures in determining whether to
conduct an affordability review for an identified prescription drug. The
bill requires the board, in making such a determination, to consider
whether the drug has an approved orphan drug designation for one or
more rare diseases and no other indications and, if so, to consider input
from consumers and the Colorado rare disease advisory council (council).
Current law requires the board, in performing an affordability
review, to consider certain information. The bill requires the board to
consider input from the council.

Committee Reports
with Amendments
Full Text
Full Text of Bill (pdf) (most recent)
Fiscal Notes Fiscal Notes (04/15/2024) (most recent)  
Additional Bill Documents Bill Documents
  • Past bill versions
  • Past fiscal notes
  • Committee activity and documents
  • Bill History
Lobbyists Lobbyists
Audio [This feature is available by subscription.]  
Votes House and Senate Votes
Vote Totals Vote Totals by Party
Copyright © 2008-2024 State Capitol Watch